A gel containing the drug tamoxifen and applied to the skin was as effective in reducing the growth of breast cancer cells in women with noninvasive cancer as the pill form of the medication — and it caused fewer side effects, according to a new study.

The paper, published Tuesday in Clinical Cancer Research, a journal of the American Association for Cancer Research, said that the gel was applied to the breasts of women diagnosed with ductal carcinoma in situ, or DCIS. All the women had DCIS that was sensitive to estrogen.

READ FULL ARTICLE Curated publisher From Washington Post